Clear Creek Financial Management’s Milestone Pharmaceuticals MIST Stock Holding History

Clear Creek Financial Management’s Portfolio MIST Stock Details MIST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,500	Closed	-$8.4K	–	568
2025 Q1	$8.4K	Hold	10,500	–	–	﹤0.01%	519
2024 Q4	$24.8K	Sell	10,500 -9,000	-46%	-$15.4K	﹤0.01%	466
2024 Q3	$29.6K	Hold	19,500	–	–	﹤0.01%	455
2024 Q2	$25.7K	Sell	19,500 -5,500	-22%	-$8.84K	﹤0.01%	443
2024 Q1	$44.8K	Sell	25,000 -6,750	-21%	-$11K	0.01%	417
2023 Q4	$53K	Buy	31,750 +321	+1%	+$871	0.01%	339
2023 Q3	$97.4K	Sell	31,429 -500	-2%	-$1.55K	0.02%	317
2023 Q2	$91K	Sell	31,929 -4,000	-11%	-$15.1K	0.02%	322
2023 Q1	$142K	Buy	+35,929	New	+$131K	0.03%	290

Other funds holding MIST

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

AFA

Alta Fundamental Advisers New York $265M AUM 98.61% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Clear Creek Financial Management's MIST Position: Q2 2025 in Review

Clear Creek Financial Management sold out of Milestone Pharmaceuticals (MIST) in Q2 2025, closing a stake of 10,500 shares — an estimated $8.4K sold.

Clear Creek Financial Management first reported a position in MIST in Q1 2023 and held it in 9 quarters. The position peaked at $142K in Q1 2023. 43 funds tracked by Wall St. Rank hold MIST as of Q2 2025.

Clear Creek Financial Management reported no remaining Milestone Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
Clear Creek Financial Management sold 10,500 Milestone Pharmaceuticals shares in Q2 2025, an estimated $8.4K.
Clear Creek Financial Management first reported a position in Milestone Pharmaceuticals in Q1 2023 and held it in 9 quarters.
Clear Creek Financial Management's Milestone Pharmaceuticals position peaked at $142K in Q1 2023.
43 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2025.

Based on Clear Creek Financial Management's 13F filing for Q2 2025, filed 23 Jul 2025.